Literature DB >> 17202300

Gene expression profiling in pulmonary hypertension.

Todd M Bull1, Christopher D Coldren, Mark W Geraci, Norbert F Voelkel.   

Abstract

The application of functional genomics toward the investigation of complex medical conditions has moved from a futuristic dream to a medical reality in less then a decade. The ability to examine the expression level of thousands of genes simultaneously has opened the door for entirely new approaches toward experimental observation and discovery. The resulting data from these genomic studies is being collected at an unprecedented scale. This wealth of data can present its own obstacles in terms of analysis. However, as new and more powerful means of examining these experiments are developed, medical science is reaping significant benefit. The power of microarray gene expression analysis has been directed at a diverse and complex array of diseases. As will be discussed in this article, the investigation of pulmonary hypertension has already benefited greatly from the application of this technology.

Entities:  

Mesh:

Year:  2007        PMID: 17202300     DOI: 10.1513/pats.200605-128JG

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  23 in total

1.  Global expression profiling and pathway analysis in two different population groups in relation to high altitude.

Authors:  Supriya Saini; Praveen Vats; Susovon Bayen; Priya Gaur; Koushik Ray; Krishna Kishore; Meerim Sartmyrzaeva; Almaz Akunov; Abdirashit Maripov; Akpay Sarybaev; Bhuvnesh Kumar; Shashi Bala Singh
Journal:  Funct Integr Genomics       Date:  2018-10-19       Impact factor: 3.410

2.  Pulmonary hypertension: have we learned enough yet?

Authors:  Davide Cattano; Marie Francoise Doursout
Journal:  Intern Emerg Med       Date:  2012-08-18       Impact factor: 3.397

3.  Alteration of pulmonary artery integrin levels in chronic hypoxia and monocrotaline-induced pulmonary hypertension.

Authors:  Anita Umesh; Omkar Paudel; Yuan-Ning Cao; Allen C Myers; James S K Sham
Journal:  J Vasc Res       Date:  2011-08-10       Impact factor: 1.934

Review 4.  Genetics of systemic sclerosis-associated pulmonary arterial hypertension: recent progress and current concepts.

Authors:  Sanjiv J Shah
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

5.  Host lung gene expression patterns predict infectious etiology in a mouse model of pneumonia.

Authors:  Scott E Evans; Michael J Tuvim; Jiexin Zhang; Derek T Larson; Cesar D García; Sylvia Martinez-Pro; Kevin R Coombes; Burton F Dickey
Journal:  Respir Res       Date:  2010-07-23

6.  Identification of candidate genes in scleroderma-related pulmonary arterial hypertension.

Authors:  Dmitry N Grigoryev; Stephen C Mathai; Micah R Fisher; Reda E Girgis; Ari L Zaiman; Traci Housten-Harris; Christopher Cheadle; Li Gao; Laura K Hummers; Hunter C Champion; Joe G N Garcia; Fredrick M Wigley; Rubin M Tuder; Kathleen C Barnes; Paul M Hassoun
Journal:  Transl Res       Date:  2008-02-01       Impact factor: 7.012

Review 7.  Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases.

Authors:  Ankit A Desai; Pirro Hysi; Joe G N Garcia
Journal:  Transl Res       Date:  2007-12-18       Impact factor: 7.012

Review 8.  A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?

Authors:  Gerald Maarman; Sandrine Lecour; Ghazwan Butrous; Friedrich Thienemann; Karen Sliwa
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

9.  Peripheral blood gene expression profiling for cardiovascular disease assessment.

Authors:  Hamza Aziz; Aimee Zaas; Geoffrey S Ginsburg
Journal:  Genomic Med       Date:  2008-02-27

10.  Murine pulmonary response to chronic hypoxia is strain specific.

Authors:  Yuji Tada; Sven Laudi; Julie Harral; Michelle Carr; Charles Ivester; Nobuhiro Tanabe; Yuichi Takiguchi; Koichiro Tatsumi; Takayuki Kuriyama; William C Nichols; James West
Journal:  Exp Lung Res       Date:  2008-08       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.